{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:50:35Z","timestamp":1791237035411,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma &amp; Immunology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.anai.2009.11.013","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T05:20:33Z","timestamp":1264569633000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria"],"prefix":"10.1016","volume":"104","author":[{"given":"Martin","family":"Metz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ferr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1aki","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gim\u00e9nez-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2009.11.013_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0091-6749(90)90037-5","article-title":"Cold urticaria syndromes: historical background, diagnostic classification, clinical and laboratory characteristics, pathogenesis, and management","volume":"85","author":"Wanderer","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.013_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.0022-202x.2001.00028.x","article-title":"Cold urticaria","volume":"6","author":"Claudy","year":"2001","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.anai.2009.11.013_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2230.2007.02376.x","article-title":"Acquired cold urticaria: clinical picture and update on diagnosis and treatment","volume":"32","author":"Siebenhaar","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.anai.2009.11.013_bib4","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1056\/NEJMicm072431","article-title":"Cold-induced urticaria","volume":"358","author":"Huissoon","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2009.11.013_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.iac.2004.01.001","article-title":"The spectrum of acquired and familial cold-induced urticaria\/urticaria-like syndromes","volume":"24","author":"Wanderer","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.anai.2009.11.013_bib6","first-page":"9","article-title":"Primary acquired cold urticaria","volume":"24","author":"Lee","year":"2003","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2009.11.013_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1600-0536.1995.tb00675.x","article-title":"Cold urticaria as an occupational dermatosis","volume":"32","author":"Fitzgerald","year":"1995","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.anai.2009.11.013_bib8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s001050050461","article-title":"Epidemiologie und Klinik der K\u00e4lteurticaria","volume":"47","author":"M\u00f6ller","year":"1996","journal-title":"Hautarzt"},{"key":"10.1016\/j.anai.2009.11.013_bib9","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jaci.2004.07.018","article-title":"Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria","volume":"114","author":"Siebenhaar","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.013_bib10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1046\/j.1398-9995.2003.00327.x","article-title":"Urticaria","volume":"58","author":"Zuberbier","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.013_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF03168446","article-title":"Role of histamine and platelet-activating factor in allergic rhinitis","volume":"60","author":"Alfaro","year":"2004","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.anai.2009.11.013_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2133.1984.tb07310.x","article-title":"Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin","volume":"110","author":"Archer","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2009.11.013_bib13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1253\/jcj.62.328","article-title":"Roles of plasma platelet-activating factor acetylhydrolase in allergic, inflammatory, and atherosclerotic diseases","volume":"62","author":"Yamada","year":"1998","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.anai.2009.11.013_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1056\/NEJM198508153130702","article-title":"Association of platelet-activating factor with primary acquired cold urticaria","volume":"313","author":"Grandel","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2009.11.013_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)36413-4","article-title":"Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)","volume":"280","author":"Merlos","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl 87","key":"10.1016\/j.anai.2009.11.013_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1398-9995.2008.01640.x","article-title":"Rupatadine in allergic rhinitis and chronic urticaria","volume":"63","author":"Mullol","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.013_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000232569","article-title":"Rupatadine inhibits proinflammatory mediador secretion from human mast cells triggered by different stimuli","volume":"151","author":"Vasiadi","year":"2009","journal-title":"Int Arch Allergy Inmunol"},{"key":"10.1016\/j.anai.2009.11.013_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00003495-200767030-00008","article-title":"Rupatadine: a review of its use in the management of allergic disorders","volume":"67","author":"Keam","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.anai.2009.11.013_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000080959","article-title":"Central and peripheral evaluation of rupatadine, a new antihistamine\/platelet-activating factor antagonist, at different doses in healthy volunteers","volume":"50","author":"Barbanoj","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.anai.2009.11.013_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hup.856","article-title":"Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers","volume":"22","author":"Vuurman","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.anai.2009.11.013_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hup.741","article-title":"Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers","volume":"21","author":"Barbanoj","year":"2006","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.anai.2009.11.013_bib22","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1517\/14656566.7.14.1989","article-title":"Rupatadine: pharmacological profile and its use in the treatment of allergic disorders","volume":"7","author":"Picado","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.anai.2009.11.013_bib23","first-page":"223","article-title":"Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study","volume":"17","author":"Dubertret","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.anai.2009.11.013_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1398-9995.2007.01330.x","article-title":"Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study","volume":"62","author":"Gim\u00e9nez-Arnau","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.013_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaci.2008.12.008","article-title":"High-dose desloratadine decreases wheal volume and improves cold provocation thresholds as compared with standard dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study","volume":"123","author":"Siebenhaar","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.013_bib26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1468-3083.2009.03289.x","article-title":"The use of a responder analyses to identify clinically meaningful differences in chronic urticaria patients following placebo-controlled treatment with rupatadine 10 and 20 mg","volume":"23","author":"Gim\u00e9nez-Arnau","year":"2009","journal-title":"J Eur Acad Dermatol Venerol"},{"issue":"10","key":"10.1016\/j.anai.2009.11.013_bib27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA(2)LEN\/EDF\/WAO guideline: management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.anai.2009.11.013_bib28","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1398-9995.2009.02177.x","article-title":"The definition and diagnostic testing of physical and cholinergic urticarias: EAACI\/GA2LEN\/EDF\/UNEV consensus panel recommendations","volume":"64","author":"Magerl","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.013_bib29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1067\/mjd.2003.144","article-title":"Mizolastine in primary acquired cold urticaria","volume":"48","author":"Dubertret","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2009.11.013_bib30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archderm.1977.01640100053005","article-title":"Primary acquired cold urticaria: double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo","volume":"113","author":"Wanderer","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anai.2009.11.013_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0091-6749(87)90014-5","article-title":"Inhibiting effect of cetirizine on histamine-induced and 48\/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria","volume":"80","author":"Juhlin","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2009.11.013_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0301-0546(02)79134-9","article-title":"Urticaria por fr\u00edo: revisi\u00f3n 12 casos","volume":"30","author":"Santoalalla","year":"2002","journal-title":"Allergol Immunopathol Madr"},{"key":"10.1016\/j.anai.2009.11.013_bib33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/j.1398-9995.2007.01500.x","article-title":"Acquired cold urticaria symptoms can be safely prevented by ebastine","volume":"62","author":"Magerl","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2009.11.013_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1098-2299(19960901)39:1<12::AID-DDR2>3.0.CO;2-N","article-title":"Dual effect of a new compound, rupatadine, on edema induced by platelet-activating factor and histamine in dogs: comparison with antihistamines and PAF antagonists","volume":"39","author":"Queralt","year":"1996","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.anai.2009.11.013_bib35","unstructured":"Barr\u00f3n S, Ramis I, Merlos M. Rupatadine inhibits the inflammatory components of allergic response: cytokine release, adhesion molecule expression and inflammatory cell recruitment. In: Abstract book from the XXIII EAACI Congress; June 12\u201316, 2004; Amsterdam, The Netherlands. Abstract 366."},{"key":"10.1016\/j.anai.2009.11.013_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/PL00000216","article-title":"In vitro inhibitory effect of rupatadine on histamine and TNF-\u03b1 release from dispersed canine skin mast cells and the human mast cell line HMC-I","volume":"49","author":"Queralt","year":"2000","journal-title":"Inflamm Res"}],"container-title":["Annals of Allergy, Asthma &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120609000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120609000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:38:08Z","timestamp":1761050288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120609000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1081120609000143"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2009.11.013","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2009.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}